奥沙利铂联合CF/5-FU持续静脉输入治疗晚期结直肠癌临床观察

下载PDF

导出

作者李海金董良李英符淑媛

机构地区中国医科大学华宇医院肿瘤内科

出处《浙江临床医学》 2007年第12期1654-1655,共2页 Zhejiang Clinical Medical Journal

关键词 CF/5-FU 晚期结直肠癌持续静脉输入奥沙利铂临床观察治疗 5-氟脲嘧啶恶性肿瘤化疗

参考文献4

1De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first - line treatment in advanced colorectal cancer. J Clin Oncol, 2000, 18(16) : 2938 - 2947.
2胡希宏.奥沙利铂亚叶酸钙 5-氟尿嘧啶联合化疗在晚期胃癌中的应用[J].浙江临床医学,2006,8(9):955-956. 被引量：3
3Goldberg RM. et al, Oxaliplatin or CPT - 11 + 5 - Fluouracil/leucovorin or Oxa + CPT - 11 in advanced colorectal cancer. Eficacy ad safety result,From a North American Gastrointestinal Intrgroup Study(9741 ). perspectic in Colorectal Cancer, Fourth Intenational Confernee,2002, abstract # 6.
4Goldstein D, Mitchell P, Michal M, et al. Australian experience ofa modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients. Br J Cancer, 2005, 92(5): 832- 837.

1Prcusser P,Wilke H,Achterrath W,et al.Phase Ⅱ study with the combination etoposide,doxorubicin,and cispatin in advanced measurable gastric ancer.J Clin Oncol,1989,7(9):1310 ～ 1317.
2Becouarn Y,Agostini C,Trufflandier N,et al.Oxaliplatin:available data in non-colorectal gastrointestinal malignancies.Crit Rev Oncol Hematol,2001,40(3):265.
3De Gramont A,Figer A,Seymonr M,et al.Leucovorin and fluorouracil with or without oxaliplatin as fist-line treatment in adavanced colorectal cancer.J Clin Oncol,2000,18:2938-2947.
4Maindrault-Goebel F,Louet C,Andre T,et al.Oxliplatin added to the simplified bimonthly leucovorin and fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6).Eur J cancer,1999,35(9):1338.
5孙燕,管忠震,金懋林,李维廉,李丽庆,石廷章,周立中,隋广杰,许立功,宋恕平,许德凤,李容,李扬,黄富麟,张嘉庆,张和平,鞠利雅.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].癌症,1999,18(3):237-240. 被引量：344
6林万隆,陈强.奥沙利铂的药理作用及临床应用[J].中国肿瘤临床,2000,27(11):872-874. 被引量：333

浙江临床医学

2007年第12期

内容加载中请稍等...